×

MAQTOX and Telomir Pharmaceuticals Present Groundbreaking Data on Telomir-1 for Age-Related Chronic

MAQTOX, in collaboration with Telomir Pharmaceuticals, has made significant strides in the fight against age-related diseases through their groundbreaking research on Telomir-1. This novel therapeutic compound has shown promising results in the extension of telomeres

MAQTOX and Telomir Pharmaceuticals Partner to Tackle Age-Related Inflammation with Telomir-1

In a significant development within the field of aging research, MAQTOX has partnered with Telomir Pharmaceuticals to tackle one of the most common and debilitating conditions associated with aging chronic inflammation. This collaboration is around their promising lead.

sdfgsdfgdfsa

MAQTOX Announces Breakthrough in Drug Discovery with New Preclinical Data for Anti-Aging Compound

MAQTOX, a leader in drug discovery and development, recently presented a groundbreaking update on one of its most promising anti-aging compounds at the 2024 National University Health System (NUHS) Singapore.

MAQTOX Partners with Telomir Pharmaceuticals to Unveil Telomir-1 Data at Singapore Longevity Conference

MAQTOX, a global leader in drug discovery and development, in partnership with Telomir Pharmaceuticals, showcased groundbreaking pre-clinical data on Telomir-1 at the NUHS Centre for Healthy Longevity Conference 2024 in Singapore.